Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Sedation
Interventions
DRUG

Dexmedetomidine

Trial Locations (10)

663-8501

Hyogo Medical University Hospital, Nishinomiya

890-8520

Kagoshima University Hospital, Kagoshima

589-8511

Kinki University Hospital, Sayama

565-0871

Osaka University Hospital, Suita

431-3192

Hamamatsu Medical University Hospital, Hamamatsu

113-8603

Nippon Medical School Hospital, Bunkyo-ku

105-8741

Jikei University Hospital, Minato-ku

162-8666

Tokyo Women's Medical University Hospital, Shinjuku-ku

160-8582

Keio University Hospital, Sinjuku-ku

409-3898

Yamanashi University Hospital, Chūō

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Maruishi Pharmaceutical

INDUSTRY

lead

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00526760 - Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects | Biotech Hunter | Biotech Hunter